Cresset Asset Management’s Globus Medical GMED Stock Holding History

Cresset Asset Management’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$376K	Buy	4,362 +784	+22%	+$70.4K	﹤0.01%	1187
2025 Q4	$312K	Buy	3,578 +14	+0.4%	+$1.06K	﹤0.01%	1280
2025 Q3	$204K	Buy	+3,564	New	+$205K	﹤0.01%	1418
2024 Q4	–	Sell	-5,801	Closed	-$415K	–	1941
2024 Q3	$415K	Sell	5,801 -524	-8%	-$37K	﹤0.01%	1632
2024 Q2	$433K	Sell	6,325 -461	-7%	-$27.5K	﹤0.01%	1513
2024 Q1	$364K	Sell	6,786 -144	-2%	-$7.74K	﹤0.01%	1483
2023 Q4	$369K	Sell	6,930 -2,527	-27%	-$123K	﹤0.01%	1388
2023 Q3	$470K	Buy	9,457 +1,868	+25%	+$104K	﹤0.01%	1216
2023 Q2	$452K	Buy	+7,589	New	+$432K	﹤0.01%	1333

Other funds holding GMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cresset Asset Management's GMED Position: Q1 2026 in Review

Cresset Asset Management increased its Globus Medical (GMED) stake by 22% in Q1 2026, buying an estimated $70.4K and bringing the position to 4,362 shares worth $376K. The position accounts for ﹤0.01% of the portfolio, ranked #1187.

Cresset Asset Management first reported a position in GMED in Q2 2023 and has held it in 9 quarters since. The position peaked at $470K in Q3 2023. 602 funds tracked by Wall St. Rank hold GMED as of Q1 2026.

Cresset Asset Management held 4,362 shares of Globus Medical worth $376K as of Q1 2026.
Cresset Asset Management bought 784 Globus Medical shares in Q1 2026, an estimated $70.4K.
Globus Medical made up ﹤0.01% of Cresset Asset Management's portfolio in Q1 2026, its #1187 holding.
Cresset Asset Management first reported a position in Globus Medical in Q2 2023 and has held it in 9 quarters since.
Cresset Asset Management's Globus Medical position peaked at $470K in Q3 2023.
602 funds tracked by Wall St. Rank held Globus Medical as of Q1 2026.

Based on Cresset Asset Management's 13F filing for Q1 2026, filed 15 May 2026.